Cargando…
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes
The tumor suppressor gene TP53 is the most frequently mutated gene in numerous cancer types, including prostate cancer (PCa). Specifically, missense mutations in TP53 are selectively enriched in PCa, and cluster to particular “hot spots” in the p53 DNA binding domain with mutation at the R273 residu...
Autores principales: | McCann, Jennifer J., Vasilevskaya, Irina A., McNair, Christopher, Gallagher, Peter, Neupane, Neermala Poudel, de Leeuw, Renée, Shafi, Ayesha A., Dylgjeri, Emanuela, Mandigo, Amy C., Schiewer, Matthew J., Knudsen, Karen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755525/ https://www.ncbi.nlm.nih.gov/pubmed/34773073 http://dx.doi.org/10.1038/s41388-021-01903-5 |
Ejemplares similares
-
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
por: Gordon, Nicolas, et al.
Publicado: (2023) -
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
por: Shafi, Ayesha A., et al.
Publicado: (2021) -
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer
por: Mandigo, Amy C., et al.
Publicado: (2022) -
PARP‐1 regulates DNA repair factor availability
por: Schiewer, Matthew J, et al.
Publicado: (2018) -
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer
por: Dylgjeri, Emanuela, et al.
Publicado: (2022)